Rhabdomyolysis-induced acute renal failure due to itraconazole and simvastatin association

Drug Metabolism and Drug Interactions

Volumn 26, Issue 2, 2011, Pages 79-80

  Roques, Sébastien ^a   Lytrivi, Maria ^a   Rusu, Daniel ^a   Devriendt, Jacques ^a   De Bels, David ^a  

^a BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

Author keywords

acute renal failure; hepatic metabolism; itraconazole; pharmacological interaction; rhabdomyolysis; simvastatin

Indexed keywords

ACENOCOUMAROL; AMLODIPINE; ITRACONAZOLE; PERINDOPRIL; SIMVASTATIN;

ACUTE KIDNEY FAILURE; AGED; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS RENAL REPLACEMENT THERAPY; DRUG WITHDRAWAL; HUMAN; INTENSIVE CARE UNIT; MALE; MUSCLE WEAKNESS; ONYCHOMYCOSIS; RHABDOMYOLYSIS;

ACUTE KIDNEY INJURY; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; ITRACONAZOLE; MALE; RHABDOMYOLYSIS; SIMVASTATIN;

EID: 80051810218     PISSN: 07925077     EISSN: None     Source Type: Journal    
DOI: 10.1515/DMDI.2011.106     Document Type: Article

References (6)

1. Williams D, Freely J. Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors. Clin Pharmakinet 2002;41:343-70. (Pubitemid 34713089)
2. Vasudevan AR, Hamirani YS, Jones PH. Safety of statins: Effects on muscle and the liver. Cleve Clin J Med 2005;72:990-3, 996-1001.
3. Ballantyne CM, Corsini A, Davidson MH, Holdaas H, Jacobson TA, Leitersdorf E, et al. Risk for myopathy with statin therapy in high-risk patients. Arch Intern Med 2003;163:553-64. (Pubitemid 36314342)
4. Prueksaritanont T, Ma B, Tu N. The human hepatic metabolism of simvastatin hydroxy acid is mediated primarily by CYP3A, and not CYP2D6. Br J Clin Pharmacol 2003;56:120-4. (Pubitemid 36886497)
5. Watkins PB. Noninvasive tests of CYP3A enzymes. Pharmacogenetics 1994;4:171-84. (Pubitemid 24269821)
6. Segaert MF, De Soete C, Vandewiele I, Verbanck J. Druginteraction-induced rhabdomyolysis. Nephrol Dial Transplant 1996;11:1846-7.